Browse by products

Featured content

  • Abinscience provides high-quality tools for studying viruses, superbugs, and parasites, including monkeypox, Ebola, and other emerging pathogens, supporting diagnostics, vaccine development, and therapeutic discovery.
  • Abinscience provides tools for studying Alzheimer's, Parkinson's, and Huntington's disease, supporting biomarkers, diagnostics, and therapy development in neuroscience.
  • Abinscience provides tools for studying therapeutic targets, including CD3E, CTLA4, PD1, PDL1, B7-H3, CEA, CD200R1, SIRPA, and CCR8, supporting biomarkers, diagnostics, and therapy development.
  • Abinscience offers anti-dsRNA antibodies (J2, K1, K2), widely recognized in virology, immunology, and RNA research for their exceptional specificity and sensitivity, empowering scientists to explore the RNA world
  • Reliable antibodies for botulinum, ricin, tetanus, and other toxins, enabling sensitive detection and toxin research.
  • High-specificity antibodies and ELISA kits for key targets like TNF-α, IL-6, IFN-γ, PD-1, and CTLA-4, enabling reliable cytokine detection and immune regulation studies.
  • Specific antibodies for MHC I, MHC II, and related molecules, supporting antigen presentation, immune response, and disease research.
  • Targeting tumor-associated carbohydrate antigens (Tn, STn, MUC1, CA15-3, CA72-4) to support cancer immunotherapy and biomarker research
  • Model organisms are vital tools used by researchers around the globe. These organisms share many genes with humans, are easily maintained in the lab, and have short generation times that make it easy to study the effects of genetic manipulations.
  • About Abinscience

    News

  • Alzheimer's disease (AD), marked by amyloid-beta plaques, tau tangles, and inflammation, has seen a paradigm shift with inflammation now recognized as a potential primary driver. Recent research highlights IL-12 as a central player in AD pathology. Studies reveal that IL-12 signaling significantly impacts amyloid-beta deposition and oligodendrocyte homeostasis. This discovery positions IL-12 as a key therapeutic target. abinScience offers a range of high-quality bioreagents, supporting research into neuroimmune mechanisms and therapeutic development.
  • Explore the molecular pathogenesis of Vibrio cholerae, host immune responses, and global vaccine development. Discover 18 high-quality antibodies and recombinant proteins from abinscience designed for cholera research, diagnostics, and vaccine evaluation.
  • Zebrafish offer remarkable advantages for vertebrate development and disease research, notably their capacity for heart regeneration. Recent findings published in Nature Cardiovascular Research highlight the role of the epigenetic regulator Hmga1, which facilitates cardiomyocyte proliferation by reducing H3K27me3 marks and reactivating embryonic genes crucial for heart regeneration. Comparative gene expression analysis between zebrafish and mouse reveals zebrafish-specific regenerative pathways, underscoring their value in translational medicine. Abinscience provides specialized recombinant proteins and antibodies to support zebrafish research across multiple fields, including neuroscience, genetics, drug screening, and developmental biology, facilitating significant advancements in biomedical science.
  • Explore high-quality TSHR recombinant proteins and antibodies from Abinscience, designed for thyroid research, Graves' disease studies, and diagnostic applications.
  • Discover how Abinscience's high-affinity, highly specific M13 monoclonal antibody enhances phage display efficiency, specificity, and reliability across ELISA, flow cytometry, and Western blot applications.
  • On February 26, 2025, a measles outbreak in Texas, marked by the first U.S. death since 2015, underscores declining vaccination rates (82% in Gaines County vs. 93% nationally) and its spread to over 124 cases. Beyond this public health challenge, the measles virus (MeV) shows promise in oncolytic virotherapy, targeting tumors via receptors like CD46 and nectin-4, inducing immune responses, and undergoing genetic engineering for cancers such as glioblastoma and multiple myeloma. Abinscience offers recombinant MeV proteins to advance research into its biology and therapeutic potential, bridging virology and oncology.
  • Explore the role of biosimilars of monoclonal antibodies in advancing cancer research. This article delves into how biosimilars are transforming drug development and providing essential tools for oncologists and researchers, enhancing the accessibility and effectiveness of biologic therapies in cancer treatment.
  • On February 18, 2025, researchers at the Wuhan Institute of Virology published groundbreaking findings in Cell journal, revealing a newly discovered bat-origin coronavirus, HKU5-CoV-2. This discovery highlights a potential new viral threat with distinctive infection mechanisms and a risk of cross-species transmission. While the study emphasizes that the virus has characteristics limiting its ability to spread among humans, the possibility of cross-species transmission remains concerning.
  • ApoE4 is a major genetic risk factor for Alzheimer’s disease (AD), contributing to lipid metabolism dysfunction, neuroinflammation, and Aβ aggregation. This article explores ApoE4’s role in AD pathology and highlights therapeutic strategies, including gene editing, immunotherapy, structural correctors, and lipidation enhancement. Targeting ApoE4 offers promising avenues for AD treatment and neuroprotection.
  • This article examines IL-17A's critical role in immune regulation and inflammation, detailing its structure, signaling pathways, and cellular sources. It also highlights advanced IL-17A reagents from Abinscience, empowering cutting-edge research in autoimmune and inflammatory diseases.
  • Semaglutide, a potent GLP-1 receptor agonist, has demonstrated remarkable efficacy in managing obesity, type 2 diabetes, and associated chronic conditions. Its rising global sales underscore its effectiveness in promoting weight loss and glycemic control, while emerging evidence highlights its potential benefits for inflammatory diseases like knee osteoarthritis. As indications expand, high-quality reagents and technical support are crucial for advancing Semaglutide research. Abinscience offers specialized ELISA kits and antibody products that empower scientists to explore the drug’s mechanisms and accelerate progress in obesity and metabolic disease therapies worldwide
  • Abinscience’s anti-dsRNA antibodies (J2, K1, K2) are industry-leading tools for detecting double-stranded RNA (dsRNA) with high specificity and sensitivity. Widely used in virology, mRNA vaccine development, and immune pathway research, these antibodies ensure precise dsRNA detection, supporting viral studies, quality control, and immunotherapy advancements.